Pharmarama International is Named One of Britain’s Leading Private Companies in International Sales Growth
Pharmaceutical Firm Ranks Eighth Among The Sunday Times HSBC International Track 100
Boston and London, July 21, 2010 – Pharmarama International, a leader in strategically sourcing comparator medicines for clinical trials worldwide, today announced that it has been ranked as Britain’s eighth fastest-growing private company for overseas sales in a 2010 survey published by the country’s leading business newspaper, The Sunday Times.
Companies were ranked on their compound annual growth rate (CAGR) based in international sales on the most recent two years of available data from 2006-2010. Pharmarama’s international sales grew at a CAGR of 131 percent between 2007 and 2009, increasing to £10.4 million for the fiscal year ended July 31, 2009. International sales for the base period were almost £2.0 million.
“Our prestigious recognition in the inaugural International Track 100 reflects the success Pharmarama has achieved in building and growing its U.S. business,” said company Managing Director Rosemary Bensley. “Since launching Pharmarama in the US in 2007, we have established our U.S. office and warehouse in Boston, Massachusetts to serve the clinical supply needs of pharmaceutical companies across North America. Our ranking among Britain’s top private companies in international sales is a significant accomplishment. It underscores the outstanding work of our employees on both sides of the Atlantic and reinforces the strong relationships we have with our customers.”
About Pharmarama and GlobalBatch™
Pharmarama is engaged in developing cost-effective strategies that enable both leading pharmaceutical and emerging biotech companies to single-source comparator medicines for worldwide clinical trials, including the United States. Through its proprietary GlobalBatch™ program, Pharmarama provides on-site client education and training, bioequivalence testing, A-Z project management and truly global sourcing for comparator studies, thereby significantly lowering procurement costs and improving trial efficiency. Pharmarama has sourced medicines for more than 417 trials since 1996. The company, a preferred supplier to many of the world’s leading pharma companies, is based in the United Kingdom and the United States with partnerships in Germany and China. More information is available at www.pharmarama.com
MassBio Membership gives you:
Purchasing power-MassBio negotiates a broad-based collection of services on behalf of member companies and passes the savings on to its members.
Networking and professional development-MassBio organizes and executes numerous conferences, committee meetings, and networking events throughout the year.
MassBio Signature Events-Attend our Investors Forum, Innovator Roundtables, Pharma Days, our Golf Classic Fundraiser, Policy Leadership Breakfast, and many others.
Public policy & Advocacy-As the state's leading advocate for our life science super cluster, we fight for public policy initiatives and tax incentives in Massachusetts and Washington, D.C., that will enable biotechnology companies to do their best work.
Economic development-MassBio provides expert advice and guidance to help companies find suitable locations and resources as they move to and grow in the Bay State. We make Massachusetts a better place for your business.
Visibility/Resources-Members are listed on a searchable directory that includes a profile and link to the company's website. We highlight your company's latest news by posting to our MassBio member news page. In addition, members can post job openings on our website free!
Educational incentives-We promote education, workforce development and lifelong learning through the MassBioEd Foundation. The foundation customizes training programs for companies and educational institutions and promotes science in the classroom through BioTeach. MassBio members receive a discount on courses offered by the foundation.